AstraZeneca Takes Full Control of Japanese Subsidiary

AstraZeneca today announced it has completed the purchase of Sumitomo Chemical's remaining shares in AstraZeneca K.K., the company’s Japanese subsidiary.

The purchase was valued at approximately JPY10 billion ($102 million) and gives AstraZeneca control of the entire shareholding of AstraZeneca K.K.

Marc Dunoyer, chief financial officer, AstraZeneca, said: “Our decision to gain full control of AstraZeneca K.K. reinforces our focus on Japan as a key growth platform.”

Source: AstraZeneca

Leave a Reply

Your email address will not be published. Required fields are marked *